Sino Biological (SZSE:301047) ROCE %

: 5.08% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sino Biological's annualized ROCE % for the quarter that ended in Sep. 2023 was 5.08%.

Sino Biological ROCE % Historical Data

The historical data trend for Sino Biological's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biological Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

62.45

154.86

184.22

20.89

5.22

Sino Biological Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %															6.24	1.32	5.74	3.95	5.08

Sino Biological ROCE % Calculation

Sino Biological's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	345.286	/	( ( (6890.235 - 98.367)	+	(6570.39 - 125.197) )	/ 2 )
	=	345.286	/	( (6791.868	+	6445.193)	/ 2 )
	=	345.286	/	6618.5305
	=	5.22 %

Sino Biological's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	322.024	/	( ( (6429.252 - 127.805)	+	(6502.124 - 129.024) )	/ 2 )
	=	322.024	/	( ( 6301.447	+	6373.1 )	/ 2 )
	=	322.024	/	6337.2735
	=	5.08 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Sino Biological (SZSE:301047) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sino Biological ROCE % Related Terms

Thank you for viewing the detailed overview of Sino Biological's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biological (SZSE:301047) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biological Inc (SZSE:301047) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 Kechuang 10th Street, Room 306, Building 9, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176

Website

https://www.sinobiological.com

Sino Biological Inc is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.

Sino Biological (SZSE:301047) Headlines

No Headlines